Michelle M. Busching, PA-C

Michelle Busching practices at UCSD Hillcrest Medical Center in San Diego, California.

Michelle Busching's NPI, 1720598808, was assigned on October 3, 2017. Michelle Busching holds California license 54908.

Michelle Busching's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Michelle Busching's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Michelle Busching is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Michelle Busching to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michelle Busching practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Michelle Busching's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Michelle Busching is licensed in California.

Dmand AI lists acne, itchy rashes, joint pain and skin cyst among the conditions Michelle Busching treats.

CMS data shows 12 Medicare services from Michelle Busching across 1 procedure code in 2024, all of them office visits, for 34 Medicare patients. Medicare paid $740 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 34 Medicare patients who saw Michelle Busching in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have cancer, and 56% have high blood pressure. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michelle Busching's median patient age at 56, with 93% women.

In 2024, Michelle Busching wrote 410 Medicare Part D claims for 143 patients. 82% of them were for generic drugs. CMS names the drug for 246 of them, across 9 drugs with 11 or more claims each, at $565,737 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Michelle Busching for performance year 2024, reported as part of a group. Michelle Busching accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michelle Busching as offering telehealth.

CMS Open Payments shows 12 general payments to Michelle Busching from 6 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $342.